Wednesday, January 14, 2009

Here Comes Latisse

We've blogged about it here and here, and Natasha Singer of the NY Times is also on the scene, with today's article "Love the Long Eyelashes. Who's Your Doctor?"

The article cites annual revenue estimates for Allergan's upcoming eye-lash lengthening drug Latisse, ranging from $80 million in 2012 (via Gary Nachman of Leerink Swan), to $500 million "long-term" (coming from Allergan CEO David Pyott).

The meat of the article comes here:

"Allergan held a clinical trial with about 280 volunteers, half of whom used Latisse daily for 16 weeks. The study results were reviewed by the Food and Drug Administration, which approved the drug in late December. In that study, eyelashes typically grew 25 percent longer, 106 percent thicker and 18 percent darker. While 3.6 percent of patients experienced eye itching and red eyes, none had a change of eye color, Allergan said."

Stay tuned for more on this... articles like this hint that Latisse may become a household name next to Botox someday.

Dr. Jason Pozner
Sanctuary Medical Aesthetic Center

Dr. David J. Goldberg
Sanctuary Medical Aesthetic Center
Skin and Laser Surgery Specialists of New York/New Jersey

1 comment:

  1. March 26, 2009 Allergan, Inc. hosted a star-studded event in Hollywood to launch LATISSE™ Wishes, a charitable public awareness campaign designed to help make wishes come true. Actress Brooke Shields and beauty expert to the stars Anastasia Soare will lead the campaign to generate $1 million to support the Make-A-Wish Foundation, a non-profit organization dedicated to granting the wishes of children with lifethreatening medical conditions.

    The LATISSE™ Wishes campaign was borne out of the tradition of blowing on an eyelash to make a wish come true and leverages the excitement surrounding the availability of Allergan’s LATISSE™ (bimatoprost ophthalmic solution) 0.03%, the first and only science-based prescription treatment approved by the U.S. Food and Drug Administration for hypotrichosis of the eyelashes (inadequate or not enough lashes) that is used to grow eyelashes, making them
    longer, fuller and darker.

    “In the short time LATISSE™ has been available, the product has already made many women’s wish lists,” said David E.I. Pyott, Chairman of the Board and Chief Executive Officer of Allergan. “While LATISSE™ may fulfill the wish for more prominent eyelashes, we also wanted to shine the spotlight on the Make-A-Wish Foundation and provide support for the important work it does in granting children’s wishes.”

    The LATISSE™ Wishes campaign launched with an initial donation of $500,000 from Allergan to the Make-A-Wish Foundation. Consumers are encouraged to help double this amount to $1 million by registering their support at to help grant the wishes of children in
    their local communities. Between now and December 31, 2009, Allergan will donate $5 for each new visitor who registers online, up to an additional $500,000.

    “Every 40 minutes the Make-A-Wish Foundation grants a wish to a child with a life-threatening medical condition. Forty seconds is all it takes to visit to register your support and help make wishes come true,” said David Williams, president and chief executive officer of the Make-A-Wish Foundation. “We urge everyone to log on to the LATISSE™ Web site and register their support to help grant the wishes of children in their communities.”

    “I am delighted to be a part of LATISSE™ Wishes, to not only help educate women on an eyelash growth product that is the first to be scientifically proven, but also to support a worthy organization such as the Make-A-Wish Foundation,” said Shields. “I remember being a child and
    blowing on an eyelash hoping my wish would come true, and as a mother I’ve passed this tradition onto my children. Through LATISSE™ Wishes and in partnership with the Make-A-Wish Foundation, we can keep the tradition alive and fulfill the hopes of so many more children
    around the country.”

    In addition to Shields and Soare, other stars including Debra Messing, Angie Harmon, Marisa Tomei, Mandy Moore, Debi Mazar, Jewel, Jennifer Coolidge and Perrey Reeves attended the red-carpet kick-off event for the LATISSE™ Wishes campaign. Over the next several months, campaign ambassadors Shields and Soare, who both use LATISSE™ solution, will travel to cities across the country hosting informational events aimed to further support the
    campaign and its goal of providing $1 million to the Make-A-Wish Foundation. Local events will be held in New York, Miami, Dallas, Minneapolis and San Francisco.

    “In my business I constantly work to help make women’s beauty wishes come true and now we can help children’s wishes come true through the LATISSE™ Wishes campaign,” said Soare. “I am excited to bring this worthy campaign to cities across the country.”
    For more information about the LATISSE™ Wishes charitable awareness campaign, please visit

    Latisse is available through prescription at Clear View Eye Care